Search

FDA takes another look at CBD, but insiders are skeptical much will change U.S. health regulators are taking their closest look in more than three years at the idea of incorporating cannabinoids into dietary supplements. But hopes are dim that Tuesday’s daylong review by the U.S. Food and Drug...

Jonathan Havens, co-chair of the Firm's Cannabis Law Practice and Food, Beverage and Agribusiness Practice, will speak at the Food and Drug Law Institute’s Annual Conference as a panelist during the session on “Preparing for Federal Legalization of Cannabis: Lessons Learned from Other Industries.”...

In just two months, from mid-November 2020 to mid-January 2021, Saul Ewing LLP's Cannabis Law Practice assisted clients in closing transactions with a combined deal value of more than $520 million. We served as: U.S. counsel to Canaccord Genuity Corp., lead underwriter of an overnight marketed...